Introduction
Prevalence of anxiety disorders in children with autism spectrum disorders (ASD) is high (van Steensel et al.
2011; White et al.
2009) and cognitive behavior therapy (CBT) is an effective treatment for anxiety disorders also for children with ASD (van Steensel and Bögels
2015; see meta-analysis of Sukhodolsky et al.
2013). However, not all children benefit equally from the intervention. More insight in predictors for treatment efficacy for this specific group of children may enhance treatment and optimize outcomes. Therefore, this study explored possible predictors of treatment efficacy for anxiety disorders in children with ASD.
CBT is considered an efficacious treatment for anxiety disorders in children without ASD (Bodden et al.
2008; Cartwright-Hatton et al.
2004; Ishikawa et al.
2007). However, approximately one-third of the treated children still meet criteria for an anxiety disorder after treatment (Cartwright-Hatton et al.
2004; Seligman and Ollendick
2011). The reason for this differential treatment response is not fully understood. Several studies have reported various (psychological) factors of the child and parent as predictors of CBT effectiveness in children without ASD. Research has examined the following child factors as possible predictors for treatment efficacy: age, internalizing psychopathology, pre-treatment comorbidity, depression and trait anxiety (Berman et al.
2000; Southam-Gerow et al.
2001). Parental psychological factors such as parental anxiety, depression, hostility, and paranoia have also been shown to predict treatment outcomes (Berman et al.
2000; Bodden et al.
2008; Creswell et al.
2008; Southam-Gerow et al.
2001). Lastly, a few family factors such as family dysfunction have been associated with poorer treatment outcomes (Crawford and Manassis
2001).
The identification of treatment predictors in child anxiety (without ASD), however, are not undisputed and research reports inconsistent findings. For example, Southam-Gerow et al. (
2001) reported that older-child age was associated with less favourable treatment response, while in other studies age was not found to be a predictor for treatment efficacy (Berman et al.
2000; Kendall et al.
1997; Treadwell et al.
1995). In addition, Berman et al. (
2000) found an association between treatment outcome and comorbidity, however, pre-treatment comorbidity was not found to be related to treatment outcome in several other studies (Kendall et al.
1997,
2001; Ollendick et al.
2008). The same inconsistent findings have been found for parental factors. For example, Berman et al. (
2000) reported that parental anxiety was not found to predict child treatment outcomes, while other studies found that parental anxiety has been correlated with poorer treatment outcomes (Bodden et al.
2008; Creswell et al.
2008).
To the best of the author’s knowledge, there are only two studies to date that have examined possible predictors of treatment efficacy for children with ASD and comorbid anxiety disorders (Conner et al.
2013; Storch et al.
2015). The study of Conner et al. (
2013) examined the relationship between parental anxiety and treatment response in adolescents with ASD. The results showed that children of more anxious parents responded equally well to treatment, however, parents of treatment responders did experience a decrease in their own anxiety while parents of treatment non-responders did not. The study of Storch et al. (
2015) showed that (1) more family accommodation (defined as strategies/behaviours that family members use to avoid the anxious child to become anxious, distressed or to have outbursts) was related to more anxiety symptom severity, (2) family accommodation was decreased after CBT treatment, and (3) family accommodation was lower in treatment responders compared to non-responders. Noteworthy is also the study of Maddox et al. (
2016) which did not evaluate treatment effectiveness based on anxiety but on social functioning. It was found that loneliness was not a significant predictor of change, but more social anxiety was related to social impairment as well treatment change. That is, individuals with more social anxiety—as compared to individuals with less social anxiety—had (1) poorer social functioning at pre-treatment, (2) demonstrated more improvement during treatment, but also (3) tended to deteriorate between treatment endpoint and the 3-month follow-up (Maddox et al.
2016).
More insight in the factors that play a role in treatment efficacy is needed and important for theory development and clinical practice. The process of isolating these variables and their relationship to treatment outcomes will enable professionals to match individual children to specific treatment programs (Sherer and Schreibman
2005) and thereby improve overall treatment efficacy. This study used the same ASD sample as described in van Steensel and Bögels (
2015) for which standard CBT was found to be effective for anxiety problems up to 2 years after treatment, and was not found to be very differently effective compared to a non-ASD sample. However, individual differences in treatment responding were also found. That is, in the current study, about 60% of the children with ASD were free from their primary anxiety disorder and about 40% were free from all anxiety disorders at the 2 years follow-up, which implies that some children benefited more than others from the treatment. Therefore, the aim of the current study was to examine which pre-treatment characteristics are related to treatment effectiveness. The research questions of the study were: (1) Are child characteristics (i.e., gender, age, and child psychopathology) related to treatment outcome? (2) Does parental anxiety (i.e., clinical anxiety levels of mothers and fathers) predict treatment outcome? (3) Is family type (i.e., un-involved families, authoritarian families, indulgent families, and authoritative families) predictive for treatment outcome?
Discussion
This exploratory study was the first to examine multiple predictors for anxiety disorder treatment effectiveness in children with ASD. Effects of several pre-treatment characteristics on the severity of children’s anxiety disorder and the intensity of the anxiety symptoms were investigated after treatment and 3 months, 1 and 2 years after completing treatment. Interesting, child characteristics (gender, age and children’s internalizing and externalizing problems) were not found to have an influence on treatment effectiveness, however, parental and family predictors did. Most consistent findings across assessments were found for paternal anxiety and family type (more specifically, children growing up in an ‘uninvolved’ or ‘authoritarian’ family). The findings related to each of these predictors will be discussed in more detail below.
Children with ASD and comorbid anxiety disorders who have anxious fathers were found to have less severe anxiety disorders than children without anxious fathers. This result seems somewhat contra intuitive, however, it is possible that families with anxious fathers reach out for treatment and professional help sooner than families without anxious fathers. Reasons for this could be that these families recognise the signs of an anxiety disorders faster, that they cannot cope with the stress and problems of having of an additional member with anxiety disorders in the family, or that the father feels he is less able to full-fill his role as a parent. In line, research demonstrated that parents’ anxiety level may influence their expectations and cognitions about their child’s emotional and behavioural reactions to anxiety provoking situations (Cobham et al.
1999), that parental locus of control and perceived control of child anxious behaviour is affected when a parent is anxious (Wheatcroft and Creswell
2007), and that parental beliefs (about their children’s anxious disposition) may be important predictors of parental behaviour and may impact the parenting strategies they use (Bögels and Brechman-Toussaint
2006).
Additionally, the analyses revealed that the anxiety symptom scores and severity of anxiety disorders of children with ASD who have non-anxious fathers decreased more compared to the anxiety severity scores of children with anxious fathers at follow-up measurements, which is in line with studies that have found parental anxiety to be a predictor of less positive treatment outcomes in clinically anxious youth without ASD (Bodden et al.
2008; Creswell et al.
2008). However, it is important to keep in mind that at the final follow-up assessment the anxiety levels of the two groups were very similar, and therefore it cannot be ruled out that the decrease for children with ASD and comorbid anxiety disorders who have non-anxious fathers is relatively strong because these children had more severe anxiety scores to begin with. Thus, having an anxious father might not necessarily be a predictor for negative treatment outcomes, but instead having an anxious father may make a family more likely to seek help with lower anxiety levels. Alternatively, or additionally, as we have only measured parental anxiety and not parental ASD symptoms, it is possible that the higher anxiety symptoms in fathers also reflect the presence of ASD symptoms in fathers. It is interesting to note, however, that no influence of maternal anxiety on anxiety severity or treatment outcomes was found.
The finding that paternal, but not maternal, anxiety predicts child anxiety treatment outcome is firstly consistent with theories about the important role of the father in the development and maintenance of anxiety disorders, and in overcoming childhood anxiety disorders, that is, by challenging the child to take risks and explore novel territory, and as such help them overcome anxiety and develop confidence (Bögels and Phares
2008; Bögels and Perotti
2011). An additional explanation of the finding that paternal, but not maternal anxiety predicts treatment outcome of anxiety in children with ASD concerns the function of fathers for children with autism. Fathers in general are found to suffer less from offspring diagnosed with ASD (see review of Karst and Vaughan Van Hecke
2012) perhaps because they expect less mutuality in contact. Related, fathers may be more capable in interacting with children with ASD, as fathers generally tend to do activities with their children, whereas mothers tend to socialise with their children (e.g., Bögels and Phares
2008; Möller et al.
2013) an area which is more difficult with children and adolescents with ASD. ASD has also been conceptualised as an extreme male brain (Baron-Cohen
2002), and so fathers may be more similar to and therefore more understanding of their ASD child. From here, it can be speculated that anxious fathers are less capable in fulfilling the paternal role that children with ASD need, for example to stimulate them to explore novel territory, as children with ASD tend to insist on sameness.
It was found that children with ASD and comorbid anxiety disorders who live in ‘un-involved families’ (families with a relatively low score on family relationship and system maintenance/family control)—as compared to other family types—tended to have less anxiety symptoms, but also the anxiety symptoms decreased less over time for these children. Un-involved families are characterized by being less supportive, cohesive and expressive (low on family relationship; Bloom
1985) and provide little control, are relatively undemanding and have a less hierarchical family structure (low on system maintenance/family control; Bloom
1985). It might be that because these family members are less cohesive, less involved with each other, and less likely to express their feelings, they recognize and report less anxiety symptoms in their children. In addition, being not so much involved with each other, being less supportive and expressive in combination with having relatively few rules and less hierarchy may be less beneficial for children with ASD overcoming their anxiety as for them a clear structure and explicit explanations of feelings, social expectations and emotions might be important to be able to understand and predict (social) situations more easily and to be able to function well. Additionally, having supportive family members might help children overcome their fears more easily and help them to prevent possible relapse, for various reasons, as supportive families may help more with the CBT homework, may help with generalisation of learned CBT skills, and may provide more of a sense of safety for the child, which may be a precondition to learn new skills.
Children with ASD and comorbid anxiety disorders from ‘authoritarian families’ were found to have more anxiety symptoms compared to children from other families. Authoritarian families are characterized by being more hierarchical and exerting more control (high on system maintenance/family control; Bloom
1985) in combination with being somewhat less supportive, cohesive and expressive (low on family relationship; Bloom
1985). Interesting, high control has been related to anxiety in children in non-ASD populations (Van der Bruggen et al.
2008), and the current study seems to confirm this finding for children with ASD. However, although children with ASD and comorbid anxiety disorders living in authoritarian families have higher levels of anxiety compared to the other families to begin with, they do respond well to treatment and show a rather fast decrease in anxiety symptoms. That is, at post-test and follow-up 1 the anxiety symptoms of children from authoritarian families were found to be decreased more—resulting in similar anxiety levels—compared to children from other families. It might be that the structure and control provided by authoritarian families works quite well for children with ASD and comorbid anxiety disorders when they have to learn new skills and face new challenges (i.e. overcoming fears) as these families may provide more clear rules, guidelines and structure, and/or may stick better to the rules, guidelines and structure of the CBT. In addition, having learnt how to cope with anxious feelings may have provided the children with ASD (and their parents) a more clear format about how to express, understand and communicate about their (anxious) feelings, which may have led to a rather quick decrease in anxiety symptoms.
Limitations of the study need to be considered. First, due to the relatively small sample size and the complexity of the models, it was not possible to enter multiple predictors at the same time and therefore multiple models were run with each predictor analysed separately. Therefore it was also not possible to examine which predictor might have more or less influence, or if predictors interact with each other. Second, the four family types that have been used in this study were based on the sample means of the two dimensions of the FFS because no cut-offs for these dimensions exist. Therefore, it is unclear to what extent the family types that were used in this study represent extremes or just mild variants of the family types. Third, other factors, such as child IQ or other parent psychopathology than anxiety, such as ASD symptoms, that were not accounted for in this study may be related to treatment effectiveness. Lastly, the group of children with ASD could not be compared to a control group of children who did not receive treatment. Therefore, it is unsure whether paternal anxiety and family type are impacting (long-term) treatment effects or if these factors are impacting the natural progression of anxiety over time. However, the results are still important as it leads to new hypotheses for future research and a better understanding of the relation between anxiety (treatment) and ASD.
This study was the first to assess multiple predictors for the effectiveness of anxiety treatment for youth with ASD. Strengths of the study include the clinical nature of the sample (children were referred to community health care centres not specifically specialized in ASD or anxiety disorders), the inclusion of family predictors, and the long term assessments. More insight in predictors of treatment efficacy can lead to treatments that are better suited for individual children and to optimize treatment effectiveness. Unfortunately, predictors that were found significant in the current study varied with respect to their consistency across assessments and across effectiveness measures (i.e., effectiveness measures based on anxiety disorder severity versus anxiety symptom severity), which makes it difficult to draw firm conclusions. The difference across effectiveness measures may have to do with the way effectiveness and the predictor is measured, and how much these measures are alike. That is, paternal anxiety (defined as clinically anxious fathers) and effectiveness related to anxiety disorder severity (ADIS) may be both more specific and disorder-like, while the underlying dimensions of the family types and the effectiveness related to anxiety symptoms (SCARED) may be somewhat broader. In addition, family functioning may be more related to symptoms and behaviors than to (specific) disorders. Despite the inconsistency, the results of this exploratory study generates new hypotheses for future research and identifies challenges for clinical practice. More specific, the study findings suggest that child characteristics may have less impact on treatment effectiveness for children with ASD and comorbid anxiety disorders, while it highlights the importance of parent and family factors.